Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Taketoshi Izawa is active.

Publication


Featured researches published by Taketoshi Izawa.


Microbiology and Immunology | 1980

A Complement Inhibitor Produced by Stachybotrys complementi, nov. sp. K-76, a New Species of Fungi Imperfecti

Wasei Miyazaki; Hisashi Tamaoka; Masanao Shinohara; Hirotsugu Kaise; Taketoshi Izawa; Yoshimasa Nakano; Taroh Kinoshita; Kyongsu Hong; Kozo Inoue

A complement inhibitor, K‐76, was isolated and purified from the culture supernatant of a fungus, Stachybotrys complementi, nov. sp. K‐76, isolated from soil of Ishigaki Island, Okinawa. K‐76 is a sesquiterpene compound and it can be oxidized to a monocarboxylic derivative (K‐76 COOH), the sodium salt of which is very soluble and much less toxic than K‐76. K‐76 and K‐76 COOH both inhibited complement activation by either the classical or alternative pathway. They inhibited generation of the factor chemotactic to human polymorphonuclear leukocytes from human serum by aggregated immunoglobulin. When sensitized erythrocytes were treated with complement in the presence of K‐76 COOH, the resulting unlysed cells were found to be in the state of EAC1, 4b, 2a, 3b. Thus K‐76 COOH is considered to block mainly the C5 intermediate step. K‐76 COOH did not inhibit any proteases or esterases tested, except when tested at high concentration.


Journal of The Chemical Society, Chemical Communications | 1979

Structure of K-76, a complement inhibitor produced by Stachybotrys complementi nov. Sp. K-76

Hirotsugu Kaise; Masanao Shinohara; Wasei Miyazaki; Taketoshi Izawa; Yoshimasa Nakano; Michiharu Sugawara; Kimio Sugiura; Kyoyu Sasaki

The structure of ‘K-76’(1), a complement inhibitor containing a spirobenzofuran unit, obtained from Stachybotrys complementi nov. sp. K-76, is reported.


Journal of Immunology | 1979

An Anticomplementary Agent, K-76 Monocarboxylic Acid: Its Site and Mechanism of Inhibition of the Complement Activation Cascade

Kyongsu Hong; Taroh Kinoshita; Wasei Miyazaki; Taketoshi Izawa; Kozo Inoue


Thrombosis and Haemostasis | 1986

The plasmin heavy chain-urokinase conjugate: a specific thrombolytic agent.

Nakayama Y; Masanao Shinohara; Tani T; Kawaguchi T; Furuta T; Taketoshi Izawa; Hirotsugu Kaise; Wasei Miyazaki; Yoshimasa Nakano


Archive | 1978

Sesquiterpene derivatives having anti-complementary activity

Wasei Miyazaki; Hirotsugu Kaise; Yoshimasa Nakano; Taketoshi Izawa; Yasuo Oshiro; Masanao Shinohara


Archive | 1979

3-0-(β-D-Glucuronopyranosyl)-soyasapogenol B

Masanao Shinohara; Yoshimasa Nakano; Hirotsugu Kaise; Taketoshi Izawa; Wasei Miyazaki


Archive | 1981

Anticomplementary agents comprising soyasapogenol B compounds

Masanao Shinohara; Yoshimasa Nakano; Hirotsugu Kaise; Taketoshi Izawa; Wasei Miyazaki


Archive | 1988

Novel pyrazinoxide compound of nf-1616-904 and a pharmaceutical composition containing the same and a process for its preparation

Yoshimasa Nakano; Michiharu Sugawara; Setsuyoshi Uetsuki; Taketoshi Izawa; Tomoyuki Kawaguchi; Akira Wada


Archive | 1987

Composition for prophylaxis and therapy of hepatitis

Masanao Shinohara; Hirotsugu Kaise; Yoshimasa Nakano; Taketoshi Izawa; Yasuo Oshiro; Wasei Miyazaki


Archive | 1991

Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same

Yoshimasa Nakano; Michiharu Sugawara; Setsuyoshi Uetsuki; Taketoshi Izawa; Tomoyuki Kawaguchi; Akira Wada

Collaboration


Dive into the Taketoshi Izawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge